Myalgic encephalomyelitis: International Consensus Criteria

B M Carruthers, M I van de Sande, K L De Meirleir, N G Klimas, G Broderick, T Mitchell, D Staines, A C P Powles, N Speight, R Vallings, L Bateman, B Baumgarten-Austrheim, D S Bell, N Carlo-Stella, J Chia, A Darragh, D Jo, D Lewis, A R Light, S Marshall-Gradisnik, I Mena, J A Mikovits, K Miwa, M Murovska, M L Pall, S Stevens, B M Carruthers, M I van de Sande, K L De Meirleir, N G Klimas, G Broderick, T Mitchell, D Staines, A C P Powles, N Speight, R Vallings, L Bateman, B Baumgarten-Austrheim, D S Bell, N Carlo-Stella, J Chia, A Darragh, D Jo, D Lewis, A R Light, S Marshall-Gradisnik, I Mena, J A Mikovits, K Miwa, M Murovska, M L Pall, S Stevens

Abstract

The label 'chronic fatigue syndrome' (CFS) has persisted for many years because of the lack of knowledge of the aetiological agents and the disease process. In view of more recent research and clinical experience that strongly point to widespread inflammation and multisystemic neuropathology, it is more appropriate and correct to use the term 'myalgic encephalomyelitis' (ME) because it indicates an underlying pathophysiology. It is also consistent with the neurological classification of ME in the World Health Organization's International Classification of Diseases (ICD G93.3). Consequently, an International Consensus Panel consisting of clinicians, researchers, teaching faculty and an independent patient advocate was formed with the purpose of developing criteria based on current knowledge. Thirteen countries and a wide range of specialties were represented. Collectively, members have approximately 400 years of both clinical and teaching experience, authored hundreds of peer-reviewed publications, diagnosed or treated approximately 50 000 patients with ME, and several members coauthored previous criteria. The expertise and experience of the panel members as well as PubMed and other medical sources were utilized in a progression of suggestions/drafts/reviews/revisions. The authors, free of any sponsoring organization, achieved 100% consensus through a Delphi-type process. The scope of this paper is limited to criteria of ME and their application. Accordingly, the criteria reflect the complex symptomatology. Operational notes enhance clarity and specificity by providing guidance in the expression and interpretation of symptoms. Clinical and research application guidelines promote optimal recognition of ME by primary physicians and other healthcare providers, improve the consistency of diagnoses in adult and paediatric patients internationally and facilitate clearer identification of patients for research studies.

© 2011 The Association for the Publication of the Journal of Internal Medicine.

References

    1. Tirelli U, Chierichetti F, Tavio M, et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med. 1998;105:54S–8S.
    1. Cook DB, Lange G, DeLuca J, Natelson BH. Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int J Neurosci. 2001;107:1–6.
    1. Chen R, Liang FX, Moriya J, et al. Chronic fatigue syndrome and the central nervous system. J Int Med Res. 2008;36:867–74.
    1. Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun. 2010;24:1209–17.
    1. Lorusso L, Mikhaylova SW, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev. 2009;8:287–91.
    1. Fletcher MA, Zeng XR, Maher K, et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV. PLoS ONE. 2010;5:e10817.
    1. Mihaylova I, DeRuyter M, Rummens JL, Basmans E, Maes M. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells. Neuro Endocrinol Lett. 2007;28:477–83.
    1. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990;28:1403–10.
    1. Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009;2:1–16.
    1. Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol. 2007;83:84–92.
    1. Behan WM, More IA, Behan PO. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. 1991;83:61–5.
    1. Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med. 2000;320:1–8.
    1. Peckerman A, LaManca JJ, Dahl KA, Chemitiganti R, Qureishi B, Natelson BH. Abnormal impedance cardiography predicts symptom severity in Chronic Fatigue Syndrome. Am J Med Sci. 2003;326:55–60.
    1. Hollingsworth KG, Jones DE, Taylor R, Blamire AM, Newton JL. Impaired cardiovascular response to standing in chronic fatigue syndrome. Eur J Clin Invest. 2010;40:608–15.
    1. Sharpe MC, Archard LC, Banatvala JE, et al. A report – chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991;84:118–21.
    1. Reeves WC, Wagner D, Nisenbaum R, et al. Chronic fatigue syndrome – a clinically empirical approach to its definition and study. BMC Med. 2005;3:19.
    1. Fukuda K, Straus SE, Hickie I, et al. Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann Intern Med. 1994;121:953–9.
    1. Jason LA, Najar N, Porter N, Reh C. Evaluating the Centers for Disease Control’s empirical chronic fatigue syndrome case definition. J Disabil Pol Studies. 2009;20:91–100. doi: . Accessed on 10 February 2011 at .
    1. Jason LA, Choi M. Dimensions and assessment of fatigue. In: Watanabe Y, Evengard B, Natelson BH, Jason LA, Kuratsune H, editors. Fatigue Science Human Health. Tokyo: Springer; 2008. pp. 1–16.
    1. Carruthers BM, Jain AK, De Meirleir KL, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 2003;11:7–116. Accessed on 20 March 2011 at .
    1. Jason LA, Torres-Harding SR, Jurgens A, Helgerson J. Comparing the Fukuda et al Criteria and the Canadian case definition for chronic fatigue syndrome. J. Chronic Fatigue Syndr. 2004;12:37–52. Accessed on 10 February 2011 at .
    1. De Becker P, McGregor N, De Meirleir K. A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome. J Intern Med. 2001;250:234–40.
    1. Rowe KS, Rowe KJ. Symptom patterns of children and adolescents with chronic fatigue syndrome. In: Singh NN, Ollendick TH, Singh AN, editors. Intern Perspective Child Adolescence Mental Health. Oxford: Elsevier Science Ltd; 2002. p. 2.
    1. Kaushik N, Fear D, Richards SC, et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol. 2005;58:826–32.
    1. Kerr JR, Burke B, Petty R, et al. Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis; a detailed analysis of gene network and clinical phenotypes. J Clin Pathol. 2008;61:730–9.
    1. Kerr JR, Petty R, Burke B, et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis. 2008;197:1171–84.
    1. Aspler AL, Bolshin C, Vernon SD, Broderick G. Evidence of inflammatory immune signalling in chronic fatigue syndrome: a pilot study of gene expression in peripheral blood. Behav Brain Funct. 2008;4:44. doi: .
    1. Broderick G, Craddock RC, Whistler T, Taylor R, Klimas N, Unger ER. Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics. 2006;7:407–19.
    1. Light AR, White AT, Hughen RW, Light KC. Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. J Pain. 2009;10:1099–112.
    1. Light AR, Bateman L, Jo D, et al. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome, and Fibromyalgia Syndrome. J Intern Med. 2011 ???: ???. May 26. doi: . [Epub ahead of print]
    1. Gräns H, Nilsson M, Dahlman-Wright K, Evengård B. Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome. J Clin Pathol. 2007;60:195–8.
    1. Narita M, Nishigami N, Narita N, et al. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun. 2003;311:264–6.
    1. Falkenberg VR, Gurbaxani BM, Unger ER, Rajeevan MS. Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association. Neuromolecular Med. 2011;13:66–76.
    1. Rajeevan MS, Smith AK, Dimulescu I, et al. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav. 2007;6:167–76.
    1. Carlo-Stella N, Bozzini S, De Silvestri A, et al. Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome. Int J Immunopathol Pharmacol. 2009;22:745–54.
    1. Goertzel BN, Pennachin C, de SouzaCoelho L, Gurbaxani B, Maloney EM, Jones JF. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics. 2006;7:475–83.
    1. Underhill JA, Mahalingam M, Peakman M, Wessely S. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogenet. 2001;28:425–8.
    1. Sullivan PF, Evengård B, Jacks A, Pedersen NL. Twin analyses of chronic fatigue in a Swedish national sample. Psychol Med. 2005;35:1327–36.
    1. Landmark-Høyvik H, Reinertsen KV, Loge JH, et al. The genetics and epigenetics of fatigue. PM R. 2010;2:456–65.
    1. Maher K, Klimas NG, Fletcher MA. Immunology. In: Jason LA, Fennell PA, Taylor RR, editors. Handbook of Chronic Fatigues. Hoboken, New Jersey & Canada: John Wiley & Sons; 2003. pp. 124–51.
    1. W.B. Saunders Company. Dorland’s Illustrated Medical Dictionary. 29th edn. Philadelphia: W.B. Saunders Company; 2000. 1049.
    1. Jason LA, Helgerson J, Torres-Harding SR, Carrico AW, Taylor RR. Variability in diagnostic criteria for chronic fatigue syndrome may result in substantial differences in patterns of symptoms and disability. Eval Health Prof. 2003;26:3–22.
    1. Jason LA, Taylor RR, Kennedy CL, et al. A factor analysis of chronic fatigue symptoms in a community-based sample. Soc Psychiatry Psychiatr Epidemiol. 2002;37:183–9.
    1. Dowsett EG, Ramsay AM, McCartney RA, Bell EJ. Myalgic encephalomyelitis – a persistent enteroviral infection? Postgrad Med J. 1990;66:526–30.
    1. Lloyd AR, Hickie I, Boughton CF, Spencer O, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust. 1990;153:522–8.
    1. Nijs J, Meeus M, McGregor NR, et al. Chronic fatigue syndrome: exercise performance related to immune dysfunction. Med Sci Sports Exerc. 2005;37:1647–54.
    1. Meeus M, Roussel NA, Truijen S, Nijs J. Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J Rehabil Med. 2010;42:884–90.
    1. Van Oosterwijck J, Nijs J, Meeus M, et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome; an experimental study. J Intern Med. 2010;268:265–78.
    1. Whiteside A, Hansen S, Chaudhuri A. Exercise lowers pain threshold in chronic fatigue syndrome. Pain. 2004;109:497–9.
    1. Yoshiuchi K, Farkas I, Natelson BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging. 2006;26:83–6.
    1. Goldstein JA. Chronic Fatigue Syndrome: The Limbic Hypothesis. Binghampton, New York: Haworth Medical Press; 1993. 19, 116.
    1. Streeten DH. Role of impaired lower-limb venous innervation in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci. 2001;321:163–7.
    1. Neary PJ, Roberts AD, Leavins N, Harrison MF, Croll JC, Sexsmith JR. Prefrontal cortex oxygenation during incremental exercise in chronic fatigue syndrome. Clin Physiol Funct Imaging. 2008;28:364–72.
    1. VanNess JM, Snell CR, Dempsey WL, Strayer DR, Stevens SR. Subclassifying chronic fatigue syndrome using exercise testing. Med Sci Sports Exerc. 2003;35:908–13.
    1. De Becker P, Roeykens J, Reynders M, McGregor N, De Meirleir K. Exercise capacity in chronic fatigue syndrome. Arch Intern Med. 2000;170:3270–7.
    1. Suárez A, Guillamó E, Roig T, et al. Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study. J Womens Health (Larchmt) 2010;19:1073–7.
    1. VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Postexertional malaise in women with chronic fatigue syndrome. J Womens Health (Larchmt) 2010;19:239–44.
    1. Vermeulen RCW, Kurk RM, Visser FC, Sluiter W, Scholte HR. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. J Transl Med. 2010;8:93. doi: .
    1. Demitrack MA, Crofford LJ. Evidence for and pathophysiologic implication of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann NY Acad Sci. 1998;840:684–97.
    1. White AT, Light AR, Hughen RW, et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiol. 2010;47:615–24.
    1. Yoshiuchi K, Cook DB, Ohashi K, et al. A real-time assessment of the effect of exercise in chronic fatigue syndrome. Physiol Behav. 2007;92:963–8.
    1. Snell CF, VanNess JM, Stayer DF, Stevens SR. Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS) In Vivo. 2005;19:387–90.
    1. Schutzer SE, Angel TE, Liu T, et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from chronic fatigue syndrome. PLoS ONE. 2011;6:e17287.
    1. Lange G, Wang S, DeLuca J, Natelson BH. Neuroimaging in chronic fatigue syndrome. Am J Med. 1998;105:50S–3S.
    1. de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage. 2005;26:777–81.
    1. Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol. 2004;4:14.
    1. Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QIM. 1995;88:767–73.
    1. Mena I, Villanueva-Meyer J. Study of cerebral perfusion by NeuroSPECT in patients with chronic fatigue syndrome. In: Hyde BM, Goldstein J, Levine P, editors. The Clinical and Scientific Basis of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome. Ottawa, Ontario & Ogdensburg, New York State: The Nightingale Research Foundation; 1992. pp. 432–8.
    1. Goldberg MJ, Mena I, Darcourt J. NeuroSPECT findings in children with chronic fatigue syndrome. J. Chronic Fatigue Syndr. 1997;3:61–6. Accessed on 22 March 2011 at .
    1. Ichise M, Salit I, Abbey S, et al. Assessment of regional cerebral perfusion by Tc-HMPAO SPECT in Chronic Fatigue Syndrome. Nucl Med Commun. 1995;13:767–72.
    1. Biswal B, Kunwar P, Natelson BH. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J Neurol Sci. 2001;301:9–11.
    1. Mathew SJ, Mao X, Keegan KA, et al. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (q)H MRS imaging study. NMR Biomed. 2009;22:251–8.
    1. Meeus M, Nijs J, Huybrechts S, Truijen S. Evidence for generalized hyperalgesia in chronic fatigue syndrome: case control study. Clin Rheumatol. 2010;29:393–8.
    1. Siemionow V, Fang Y, Calabrese L, Sahgal V, Yue GH. Altered central nervous system signal during motor performance in chronic fatigue syndrome. Clin Neurophysiol. 2004;115:2372–81.
    1. Lange G, Steffner J, Cook DB, et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage. 2005;26:513–4.
    1. Flor-Henry P, Lind JC, Koles ZJ. EEG source analysis of chronic fatigue syndrome. Psychiatry Res. 2010;181:155–65.
    1. Cook DB, O’Connor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among fatigue syndrome patients and controls. Neuroimage. 2007;36:108–22.
    1. Michiels V, Cluydts R, Fischler B. Attention and verbal learning in patients with chronic fatigue syndrome. J Int Neuropsychol Soc. 1998;4:456–66.
    1. Lombardi VC, Ruscetti FW, Das Gupa J, et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science. 2009;326:585–9.
    1. Lo SC, Pripuzova N, Li B, et al. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci USA. 2010;107:15874–9.
    1. Chia J, Chia A, Voeller M, Lee T, Chang R. Acute enterovirus infection followed by myalgia encephalomyelitis/chronic fatigue syndrome and viral persistence. J Clin Pathol. 2010;63:163–8.
    1. Chia J, Chia A. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol. 2008;61:43–8.
    1. Chia JK. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol. 2005;58:1126–32.
    1. Zang L, Gough J, Christmas D, et al. Microbial infections in eight genomic subtypes of chronic fatigue syndrome myalgic encephalomyelitis. J Clin Pathol. 2010;63:156–64.
    1. Ablashi DV, Eastman HB, Owen CB. Frequent HHV-6 antibody and HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000;16:179–91.
    1. Chapenko S, Krumina A, Koziereva S, et al. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome. J Clin Virol. 2006;37(Suppl 1):S47–51.
    1. Nicolson GL, Gan R, Haiser J. Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS. 2003;111:557–66.
    1. Chia JK, Chia LY. Chronic Chlamydia pneumonia infection: a treatable cause of chronic fatigue syndrome. Clin Infect Dis. 1999;29:452–3.
    1. Beqaj SH, Lerner AM, Fitzgerald JD. Immunoassay with cytomegalovirus early antigens from gene products P52 and CM 2 (UL44 and UL 57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol. 2008;61:623–6.
    1. Kerr JR, Cunniffe VS, Kelleher P, Bernstein RM, Bruce IN. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome. Clin Infect Dis. 2003;36:e100–6.
    1. Sheedy JR, Richards EH, Wettenhall REH, et al. Increased D-lactic acid intestinal bacteria in patients with Chronic Fatigue Syndrome. In Vivo. 2009;23:621–8.
    1. Brenu EW, Staines DR, Baskurt OK, et al. Immune and hemorheological changes in chronic fatigue syndrome. J Transl Med. 2010;8:1.
    1. Klimas NG, Koneru AO. Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Curr Rheumatol Rep. 2007;9:483–7.
    1. Fletcher MA, Zeng XR, Barnes Z, Levis S, Klimas NG. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009;7:96.
    1. Cameron B, Hirschberg DL, Rosenberg-Hassan Y, Ablashi D, Lloyd AR. Serum cytokine levels in postinfective fatigue syndrome. Clin Infect Dis. 2010;50:278–9.
    1. Carlo-Stella N, Badulli C, De Sivestri A, et al. The first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol. 2006;24:179–82.
    1. De Meirleir K, Bisbal C, Campine I, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med. 2000;108:99–105.
    1. Sudolnik RJ, Peterson DL, O’Brien K, et al. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res. 1997;17:377–85.
    1. Nijs J, Frémont M. Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications. Expert Opin Ther Targets. 2008;12:281–9.
    1. Nijs J, De Meirleir K, Meeus M, McGregor Nr, Englebienne P. Chronic fatigue syndrome: intracellular immune deregulations as a possible etiology for abnormal exercise response. Med Hypotheses. 2004;62:759–65.
    1. Wong R, Lopaschuk G, Zhu G, et al. Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy. Chest. 1992;102:1716–22.
    1. Jammes Y, Steinberg JG, Mambrini O, Brégeon F, Delliaux S. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med. 2005;257:299–310.
    1. Miwa K, Fujita M. Fluctuation of serum vitamin E (alphatocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart Vessels. 2010;25:319–23.
    1. Richards RS, Wang L, Jelinek H. Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med Res. 2007;38:94–8.
    1. Pall ML, Satterlee JD. Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder. Ann NY Acad Sci. 2001;933:323–9.
    1. Kurup RK, Kurup PA. Hypothalamic digoxin, cerebral chemical dominance and myalgic encephalomyelitis. Int J Neurosci. 2003;113:683–701.
    1. Pall ML. Explaining “Unexplained Illnesses”: Disease Paradigm for Chronic Fatigue Syndrome, Multiple Chemical Sensitivity, Fibromyalgia, Post-Traumatic Stress Disorder, Gulf War Syndrome and Others. Binghamton, NY: Harrington Park (Haworth) Press; 2007.
    1. Chaudhuri A, Watson WS, Pearn J, Behan PO. The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med Hypotheses. 2000;54:59–63.
    1. Miwa K, Fujita M. Cardiac function fluctuates during exacerbation and remission in young adults with chronic fatigue syndrome and “small heart”. J Cardiol. 2009;54:29–35.
    1. Miwa K, Fujita M. Small heart syndrome in patients with chronic fatigue syndrome. Clin Cardiol. 2008;31:328–33.
    1. Peckerman A, LaManca JJ, Qureishi B, et al. Baroreceptor reflex and integrative stress responses in chronic fatigue syndrome. Psychosom Med. 2003;65:889–95.
    1. Lerner AM, Lawrie C, Dworkin HS. Repetitively negative changing T waves at 24-h electrocardiographic monitors in patients with the chronic fatigue syndrome. Left ventricular dysfunction in a cohort. Chest. 1993;104:1417–21.
    1. Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med. 1998;105:15S–21S.
    1. Newton JL, Sheth A, Shin J, et al. Lower ambulatory blood pressure in chronic fatigue syndrome. Psychosom Med. 2009;71:361–5.
    1. Costigan A, Elliott C, McDonald C, Newton JL. Orthostatic symptoms predict functional capacity in chronic fatigue syndrome: implications for management. QJM. 2010;103:589–95.
    1. Burton AR, Rahman K, Kadota Y, Lloyd A, Vollmer-Conna U. Reduced heart rate variability predicts poor sleep quality in case-control study of chronic fatigue syndrome. Exp Brain Res. 2010;204:71–8.
    1. Nisenbaum R, Reyes M, Mawle AC, Reeves WC. Factor analysis of unexplained severe fatigue and interrelated symptoms: overlap with criteria for chronic fatigue syndrome. Am J Epidemiol. 1998;148:72–7.
    1. Priebe S, Fakhoury WK, Henningsen P. Functional incapacity and physical and psychological symptoms: how they interconnect in chronic fatigue syndrome. Psychopathology. 2008;41:339–45.
    1. Carmel L, Efroni S, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS. Gene expression profile of empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics. 2006;7:375–86.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅